Main > EAR NOSE THROAT (ENT) > Tumor Necrosis Factor AntAgonist > MAb Type TNF AntAgonist. > Etanercept; InflixiMAb Etc. > Immune Cochlear Vestibular Disorde > Patent. > Claims > Claim 1: Immune Ear Disorder Treat > Adm. TNF AntAgonist. Claim 3: > Immune CochlearVestibular Disorder > Claim 4: Hearing Impairment. Claim > 5: AutoImmune-Mediated. Claim 6: > Affects Inner Ear. Claim 9: TNF

---

Affects Inner Ear. Claim 9: TNF's subsections
AntAgonist: Etanercept. Claim 10:

Affects Inner Ear. Claim 9: TNF's products
This section has no products